Log In
Print
BCIQ
Print
Print this Print this
 

Treximet, sumatriptan/naproxen (formerly Trexima)

  Manage Alerts
Collapse Summary General Information
Company Pozen Inc.
DescriptionCombination of sumatriptan and naproxen sodium
Molecular Target Serotonin (5-HT1B) receptor ; Serotonin (5-HT1D) receptor
Mechanism of ActionSerotonin (5-HT1B) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMigraine
Indication DetailsTreat acute migraine; Treat migraine in patients with a poor response or intolerance to short-acting triptan treatment; Treat probable migraine
Regulatory Designation

Partner

GlaxoSmithKline plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today